Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HB55
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0002161 | aminoacyl-tRNA editing activity | 5 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0051499 | D-aminoacyl-tRNA deacylase activity | 6 | 11 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
GO:0051500 | D-tyrosyl-tRNA(Tyr) deacylase activity | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 210 | 214 | PF00656 | 0.563 |
CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.342 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.372 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.199 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.344 |
DEG_APCC_DBOX_1 | 79 | 87 | PF00400 | 0.405 |
DEG_COP1_1 | 218 | 227 | PF00400 | 0.455 |
DOC_CYCLIN_RxL_1 | 146 | 156 | PF00134 | 0.455 |
DOC_MAPK_gen_1 | 127 | 134 | PF00069 | 0.455 |
DOC_MAPK_gen_1 | 173 | 181 | PF00069 | 0.546 |
DOC_MAPK_HePTP_8 | 71 | 83 | PF00069 | 0.467 |
DOC_MAPK_MEF2A_6 | 104 | 112 | PF00069 | 0.536 |
DOC_MAPK_MEF2A_6 | 127 | 134 | PF00069 | 0.601 |
DOC_MAPK_MEF2A_6 | 74 | 83 | PF00069 | 0.589 |
DOC_PP1_RVXF_1 | 175 | 182 | PF00149 | 0.559 |
DOC_PP2B_LxvP_1 | 163 | 166 | PF13499 | 0.532 |
DOC_PP4_FxxP_1 | 15 | 18 | PF00568 | 0.494 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.563 |
DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.612 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.490 |
LIG_14-3-3_CanoR_1 | 150 | 155 | PF00244 | 0.501 |
LIG_BIR_III_4 | 213 | 217 | PF00653 | 0.563 |
LIG_BRCT_BRCA1_1 | 177 | 181 | PF00533 | 0.612 |
LIG_BRCT_BRCA1_1 | 238 | 242 | PF00533 | 0.608 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.552 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.594 |
LIG_FHA_2 | 120 | 126 | PF00498 | 0.539 |
LIG_FHA_2 | 17 | 23 | PF00498 | 0.489 |
LIG_FHA_2 | 208 | 214 | PF00498 | 0.499 |
LIG_LIR_Apic_2 | 12 | 18 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 136 | 147 | PF02991 | 0.607 |
LIG_LIR_Gen_1 | 178 | 189 | PF02991 | 0.580 |
LIG_LIR_Gen_1 | 195 | 204 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 136 | 142 | PF02991 | 0.607 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.580 |
LIG_LIR_Nem_3 | 195 | 200 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 229 | 233 | PF02991 | 0.614 |
LIG_LIR_Nem_3 | 27 | 31 | PF02991 | 0.488 |
LIG_PCNA_PIPBox_1 | 135 | 144 | PF02747 | 0.566 |
LIG_PDZ_Class_2 | 257 | 262 | PF00595 | 0.532 |
LIG_Pex14_2 | 256 | 260 | PF04695 | 0.608 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.741 |
LIG_SH2_STAT5 | 99 | 102 | PF00017 | 0.544 |
LIG_SUMO_SIM_anti_2 | 161 | 166 | PF11976 | 0.532 |
LIG_SUMO_SIM_par_1 | 149 | 156 | PF11976 | 0.549 |
LIG_SUMO_SIM_par_1 | 29 | 35 | PF11976 | 0.474 |
LIG_TRAF2_1 | 122 | 125 | PF00917 | 0.455 |
LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.580 |
LIG_TRAF2_1 | 65 | 68 | PF00917 | 0.483 |
LIG_WRC_WIRS_1 | 25 | 30 | PF05994 | 0.489 |
LIG_WRC_WIRS_1 | 54 | 59 | PF05994 | 0.488 |
MOD_CDC14_SPxK_1 | 143 | 146 | PF00782 | 0.612 |
MOD_CDK_SPxK_1 | 140 | 146 | PF00069 | 0.612 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.488 |
MOD_CK2_1 | 111 | 117 | PF00069 | 0.455 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.433 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.577 |
MOD_CK2_1 | 16 | 22 | PF00069 | 0.492 |
MOD_CK2_1 | 215 | 221 | PF00069 | 0.485 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.489 |
MOD_GlcNHglycan | 188 | 192 | PF01048 | 0.326 |
MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.382 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.464 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.583 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.493 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.608 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.486 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.323 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.612 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.459 |
MOD_PIKK_1 | 4 | 10 | PF00454 | 0.494 |
MOD_PIKK_1 | 84 | 90 | PF00454 | 0.455 |
MOD_PK_1 | 175 | 181 | PF00069 | 0.612 |
MOD_Plk_1 | 116 | 122 | PF00069 | 0.480 |
MOD_Plk_1 | 207 | 213 | PF00069 | 0.556 |
MOD_Plk_1 | 34 | 40 | PF00069 | 0.461 |
MOD_Plk_2-3 | 117 | 123 | PF00069 | 0.549 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.455 |
MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.612 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.486 |
TRG_DiLeu_BaEn_1 | 159 | 164 | PF01217 | 0.636 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.594 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.583 |
TRG_ER_diArg_1 | 126 | 128 | PF00400 | 0.542 |
TRG_Pf-PMV_PEXEL_1 | 150 | 155 | PF00026 | 0.255 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKW6 | Leptomonas seymouri | 75% | 100% |
A0A0S4JLF2 | Bodo saltans | 36% | 100% |
A0A1X0P9Y0 | Trypanosomatidae | 48% | 100% |
A0A3S7X8A0 | Leishmania donovani | 79% | 100% |
A0A422NEP7 | Trypanosoma rangeli | 45% | 100% |
A4IAA2 | Leishmania infantum | 79% | 100% |
C9ZLZ1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9B5C5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
P84066 | Leishmania major | 81% | 100% |
Q4Q2K8 | Leishmania major | 80% | 100% |